(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Zanubrutinib
Acalabrutinib
Update Venetoclax in CLL
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients
Cancer.gov
CLL Society